1-209762660-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_025228.4(TRAF3IP3):c.491G>T(p.Arg164Leu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000669 in 1,344,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_025228.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRAF3IP3 | NM_025228.4 | c.491G>T | p.Arg164Leu | missense_variant, splice_region_variant | 4/17 | ENST00000367025.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRAF3IP3 | ENST00000367025.8 | c.491G>T | p.Arg164Leu | missense_variant, splice_region_variant | 4/17 | 1 | NM_025228.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 3AN: 75896Hom.: 0 Cov.: 19
GnomAD4 exome AF: 0.00000473 AC: 6AN: 1268990Hom.: 0 Cov.: 32 AF XY: 0.00000483 AC XY: 3AN XY: 621586
GnomAD4 genome AF: 0.0000395 AC: 3AN: 75896Hom.: 0 Cov.: 19 AF XY: 0.0000265 AC XY: 1AN XY: 37726
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2024 | The c.491G>T (p.R164L) alteration is located in exon 4 (coding exon 2) of the TRAF3IP3 gene. This alteration results from a G to T substitution at nucleotide position 491, causing the arginine (R) at amino acid position 164 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at